Feasibility study of a single‐handed inserter for levonorgestrel 52 mg intrauterine device placement-Reference-Cited by-同舟云学术

Feasibility study of a single‐handed inserter for levonorgestrel 52 mg intrauterine device placement

Published:2023-12-02 Issue:1 Volume:3 Page:
ISSN:2768-7228
Container-title:Reproductive, Female and Child Health
language:en
Short-container-title:Repro Female Child Health

Author:

Eisenberg David L.¹,Schreiber Courtney A.²,Blumenthal Paul D.³,Turok David K.⁴,Olariu Andrea I.⁵,Creinin Mitchell D.⁶^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology Washington University in St. Louis St. Louis Missouri USA

2. Department of Obstetrics and Gynecology University of Pennsylvania Philadelphia Pennsylvania USA

3. Department of Obstetrics and Gynecology Stanford University Palo Alto California USA

4. Department of Obstetrics and Gynecology University of Utah Salt Lake City Utah USA

5. Medicines360 San Francisco California USA

6. Department of Obstetrics and Gynecology University of California, Davis Sacramento California USA

Abstract

AbstractObjectiveTo assess placement outcomes using a levonorgestrel 52 mg intrauterine device (IUD) inserter designed for single‐handed use.MethodsInvestigators enroled participants 18–45 years to have the IUD inserted using a redesigned inserter with removal 5–15 min after placement. Physicians and participants provided feedback on their insertion experience.ResultsSuccessful placement occurred in 48 of 50 (96.0%) enroled participants. Investigators rated insertion device loading “easy” in 49 (98.0%) and placement “easy” in 44 (88.0%) cases. Cramping pain was reported at insertion by 47 (94.0%) participants, mostly mild (32 [64.0%]) or moderate (11 [22.0%]).ConclusionThe single‐handed inserter is easy to use and results in high rates of insertion success.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rfc2.68

Reference8 articles.

1. Thirty years of mirena: A story of innovation and change in women’s healthcare

2. United States Food and Drug Administration Center for Drug Evaluation and Research. Liletta (levonorgestrel‐releasing intrauterine system) clinical review. 2015. Accessed July 9 2023.https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206229Orig1s000MedR.pdf

3. Reducing Pain During Intrauterine Device Insertion

4. Paracervical Block for Intrauterine Device Placement Among Nulliparous Women

5. Intracervical block for levonorgestrel-releasing intrauterine system placement among nulligravid women: a randomized double-blind controlled trial